MiR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1

Journal of Pathology

Volumn 227, Issue 4, 2012, Pages 470-480

  Xia, Jintang ^a,b   Wu, Zhiqiang ^c   Yu, Chunping ^d   He, Weiling ^a   Zheng, Haiqing ^a   He, Yulong ^a   Jian, Weihua ^a,b   Chen, Lianzhou ^a   Zhang, Luanjing ^a   Li, Wen ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

FOXO1; gastric cancer; miR 124; proliferation; SPHK1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA 124; PROTEIN KINASE B; SPHINGOSINE KINASE 1; TRANSCRIPTION FACTOR FKHR;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

EID: 84863718549     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4030     Document Type: Article

References (45)

1. Jiang Y, Ajani JA,. Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol 2010; 26: 640-646.
2. Roder DM,. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 (suppl 1): 5-11.
3. Buehrer BM, Bell RM,. Sphingosine kinase: properties and cellular functions. Adv Lipid Res 1993; 26: 59-67.
4. Pitson SM,. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 2011; 36: 97-107.
5. Li W, Yu CP, Xia JT, et al., Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2009; 15: 1393-1399.
6. Liu G, Zheng H, Zhang Z, et al., Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC Cancer 2010; 10: 495.
7. Song L, Xiong H,., Li J, et al,. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-ΰB pathway in human non-small cell lung cancer. Clin Cancer Res 2011; 17: 1839-1849.
8. Kawamori T, Kaneshiro T, Okumura M, et al., Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 2009; 23: 405-414.
9. Fuereder T, Hoeflmayer D, Jaeger-Lansky A, et al., Sphingosine kinase 1 is a relevant molecular target in gastric cancer. Anticancer Drugs 2011; 22: 245-252.
10. Carthew RW,. Gene regulation by microRNAs. Curr Opin Genet Dev 2006; 16: 203-208.
11. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355.
12. Lai EC,. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-364.
13. Calin GA, Sevignani C, Dumitru CD, et al., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999-3004.
14. Cho WC,. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60.
15. Johnson SM, Grosshans H, Shingara J, et al., RAS is regulated by the let-7 micro-RNA family. Cell 2005; 120: 635-647.
16. Jiang L, Mao P, Song L, et al., miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 2010; 177: 29-38.
17. Nishida N, Yokobori T, Mimori K, et al., MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol 2011; 38: 1437-1443.
18. Sato F, Tsuchiya S, Meltzer SJ, et al., MicroRNAs and epigenetics. FEBS J 2011; 278: 1598-1609.
19. Lagos-Quintana M, Rauhut R, Yalcin A, et al., Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735-739.
20. Ando T, Yoshida T, Enomoto S, et al., DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009; 124: 2367-2374.
21. Smoot DT, Sewchand J, Young K, et al., A method for establishing primary cultures of human gastric epithelial cells. Methods Cell Sci 2000; 22: 133-136.
22. Hahn WC, Dessain SK, Brooks MW, et al., Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 2111-2123.
23. Lin C, Wu Z, Lin X, et al., Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through up-regulation of FOXO3a. Clin Cancer Res 2011; 17: 3089-3099.
24. Li J, Yang L, Song L, et al., Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009; 28: 3188-3196.
25. Tang ED, Nunez G, Barr FG, et al., Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 1999; 274: 16741-16746.
26. Medema RH, Kops GJ, Bos JL, et al., AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404: 782-787.
27. Kops GJ, Medema RH, Glassford J, et al., Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol. 2002; 22: 2025-2036.
28. Schmidt M, Fernandez de Mattos S, van der Horst A, et al., Cell cycle inhibition by FOXO forkhead transcription factors involves down-regulation of cyclin D. Mol Cell Biol 2002; 22: 7842-7852.
29. Aoki M, Jiang H, Vogt PK,. Proteasomal degradation of the FOXO1 transcriptional regulator in cells transformed by the P3K and Akt oncoproteins. Proc Natl Acad Sci USA 2004; 101: 13613-13617.
30. Huang H, Regan KM, Wang F, et al., Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 2005; 102: 1649-1654.
31. Cardozo T, Pagano M,. The SCF ubiquitin ligase: insights into a molecular mechanism. Nat Rev Mol Cell Biol 2004; 5: 739-753.
32. Paugh BS, Bryan L, Paugh SW, et al., Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells. J Biol Chem 2009; 284: 3408-3417.
33. Anelli V, Gault CR, Cheng AB, et al., Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem 2008; 283: 3365-3375.
34. Ramachandran S, Shida D, Nagahashi M, et al., Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent up-regulation of sphingosine kinase 1 transcription. FEBS Lett 2010; 584: 4077-4082.
35. Shida D, Fang X, Kordula T, et al., Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 2008; 68: 6569-6577.
36. Imamura T, Yamamoto S, Ohgane J, et al., Non-coding RNA directed DNA demethylation of Sphk1 CpG island. Biochem Biophys Res Commun 2004; 22: 593-600.
37. Gregory RI, Shiekhattar R,. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
38. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
39. Esquela-Kerscher A, Slack FJ,. Oncomirsâ€"microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
40. Wilting SM, van Boerdonk RA, Henken FE, et al., Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010; 9: 167.
41. Pierson J, Hostager B, Fan R, et al., Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 2008; 90: 1-7.
42. Arden KC,. FoxOs in tumor suppression and stem cell maintenance. Cell 2007; 128: 235-237.
43. Greer EL, Brunet A,. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005; 24: 7410-7425.
44. Vogt PK, Jiang H, Aoki M,. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005; 4: 908-913.
45. Plas DR, Thompson CB,. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 2003; 278: 12361-12366.